Delivery Order SPE2DR25D3801-SPE2DR26F6QJE
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,322.79 to AmerSourceBergen Drug Corp for the supply of Verapamil SR 240 mg capsules (100-count units) on January 15, 2026, with completion expected by January 16, 2026. This non-set-aside, firm fixed-price delivery order was competitively awarded and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerSourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $2,565.47 to AmerisourceBergen Drug Corp for the supply of Verapamil SR 120 mg capsules (100-count units) on January 13, 2026. This is a firm fixed-price, non-set-aside contract with a completion date of January 14, 2026, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Verapamil SR 180 mg capsules (100 count) on December 23, 2025, with a ceiling value of $1,565.71 and completion date of December 24, 2025. This firm fixed-price, non-set-aside delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Verapamil ER PM 300 mg capsules (100 count) with a ceiling value of $7,342.97. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be delivered to the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Verapamil SR 360 mg capsules (100 count) on January 5, 2026, with a ceiling value of $1,145.13 and completion date of January 6, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a child contract under AmerisourceBergen's broader pharmaceutical supply agreement with DLA. The product will be delivered to the contractor's facility in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Verapamil SR 180 mg capsules (100 count) with a ceiling value of $1,691.01 and a firm fixed price structure. This is a non-set-aside competitive award with an ultimate completion date of August 11, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,805.92 to supply Verapamil SR 360 mg capsules (100-count units) with an ultimate completion date of November 14, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a straightforward pharmaceutical procurement from the vendor's place of performance in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for Verapamil ER PM 300 mg capsules (100-count units) with a ceiling value of $1,424.91 and an ultimate completion date of August 4, 2025. This is a firm fixed price delivery order with no set-aside designation, reflecting open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerSourceBergen Drug Corp on January 16, 2026, for the supply of Verapamil 5 mg/2 ml vials with a ceiling value of $1,104.11 under a firm fixed-price contract. The order is scheduled for ultimate completion by January 20, 2026, and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. This contract was competitively awarded without set-aside provisions, reflecting the contractor's capability to meet federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Verapamil ER PM 300 mg capsules (100-count units) under a firm fixed-price contract with a ceiling value of $1,764.36. The award was issued on December 29, 2025, with an ultimate completion date of December 30, 2025, and represents a non-competitive delivery order executed without a set-aside designation. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken,...
- SPE2DR25D3801Indefinite Delivery Contract
- SPE2DR25D3801-SPE2DR26F6QJEDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerSourceBergen Drug Corp on January 20, 2026, for the supply of Verapamil SR 240 mg capsules (100 count) with a contract value of $3,683.36. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of January 21, 2026. AmerSourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement needs, particularly supporting military and veteran healthcare systems. This delivery order is issued under AmerSourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This comprehensive pharmaceutical prime vendor contract enables the company to supply an extensive range of pharmaceutical products and medical supplies globally to support military healthcare programs, including medications, vaccines, syringes, vials, and specialized medical commodities across multiple therapeutic domains. The parent company, Cencora, Inc., also maintains a separate $999,999,999.00 IDC with DLA Troop Support Medical extending through December 2031, further demonstrating the company's significant role in the federal pharmaceutical supply chain for defense and healthcare agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 1/19/26 |